Tong Wooi Chng, MD | |
55 W 96th St, 1e, Bloomington, MN 55420-4370 | |
(952) 303-4664 | |
Not Available |
Full Name | Tong Wooi Chng |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 55 W 96th St, Bloomington, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619294360 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 51878 (Minnesota) | Primary |
Entity Name | Weill Medical College Of Cornell |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124170212 PECOS PAC ID: 6800709023 Enrollment ID: O20031118000661 |
News Archive
Kaiser Health News / McClatchy: "Offering the latest tough-love strategy to reduce the nation's debt, a panel of high-profile Republicans and Democrats is scheduled on Wednesday to recommend that Medicare beneficiaries pick up far more of their health care costs and the government substantially curb the amount both Medicare and Medicaid programs can grow in future years." The panel will present the findings of the debt reduction task force that was created by the Bipartisan Policy Center.
Most U.S. residents are not aware of a Bush administration proposal to cut Medicare reimbursements for physician services by 5.1% for 2007, but when informed, a majority say they are concerned that the cuts could restrict access, according to a survey released on Thursday by the American Medical Association, the Raleigh News & Observer reports.
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
Schering-Plough Corporation has announced that it has extended to stage two an ongoing Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. In this study, vicriviroc is being evaluated in a novel nucleoside-sparing regimen that is designed to provide additional options for treatment-naive patients in a once daily regimen, while preserving other drug classes for subsequent lines of treatment.
› Verified 4 days ago
Entity Name | Maimonides Faculty Practice Plan |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053344846 PECOS PAC ID: 7012808348 Enrollment ID: O20040324000597 |
News Archive
Kaiser Health News / McClatchy: "Offering the latest tough-love strategy to reduce the nation's debt, a panel of high-profile Republicans and Democrats is scheduled on Wednesday to recommend that Medicare beneficiaries pick up far more of their health care costs and the government substantially curb the amount both Medicare and Medicaid programs can grow in future years." The panel will present the findings of the debt reduction task force that was created by the Bipartisan Policy Center.
Most U.S. residents are not aware of a Bush administration proposal to cut Medicare reimbursements for physician services by 5.1% for 2007, but when informed, a majority say they are concerned that the cuts could restrict access, according to a survey released on Thursday by the American Medical Association, the Raleigh News & Observer reports.
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
Schering-Plough Corporation has announced that it has extended to stage two an ongoing Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. In this study, vicriviroc is being evaluated in a novel nucleoside-sparing regimen that is designed to provide additional options for treatment-naive patients in a once daily regimen, while preserving other drug classes for subsequent lines of treatment.
› Verified 4 days ago
Entity Name | Mmc Pediatrics Faculty Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285648154 PECOS PAC ID: 0143406918 Enrollment ID: O20110511000496 |
News Archive
Kaiser Health News / McClatchy: "Offering the latest tough-love strategy to reduce the nation's debt, a panel of high-profile Republicans and Democrats is scheduled on Wednesday to recommend that Medicare beneficiaries pick up far more of their health care costs and the government substantially curb the amount both Medicare and Medicaid programs can grow in future years." The panel will present the findings of the debt reduction task force that was created by the Bipartisan Policy Center.
Most U.S. residents are not aware of a Bush administration proposal to cut Medicare reimbursements for physician services by 5.1% for 2007, but when informed, a majority say they are concerned that the cuts could restrict access, according to a survey released on Thursday by the American Medical Association, the Raleigh News & Observer reports.
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
Schering-Plough Corporation has announced that it has extended to stage two an ongoing Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. In this study, vicriviroc is being evaluated in a novel nucleoside-sparing regimen that is designed to provide additional options for treatment-naive patients in a once daily regimen, while preserving other drug classes for subsequent lines of treatment.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Tong Wooi Chng, MD 55 W 96th St, 1e, Bloomington, MN 55420-4370 Ph: (952) 303-4664 | Tong Wooi Chng, MD 55 W 96th St, 1e, Bloomington, MN 55420-4370 Ph: (952) 303-4664 |
News Archive
Kaiser Health News / McClatchy: "Offering the latest tough-love strategy to reduce the nation's debt, a panel of high-profile Republicans and Democrats is scheduled on Wednesday to recommend that Medicare beneficiaries pick up far more of their health care costs and the government substantially curb the amount both Medicare and Medicaid programs can grow in future years." The panel will present the findings of the debt reduction task force that was created by the Bipartisan Policy Center.
Most U.S. residents are not aware of a Bush administration proposal to cut Medicare reimbursements for physician services by 5.1% for 2007, but when informed, a majority say they are concerned that the cuts could restrict access, according to a survey released on Thursday by the American Medical Association, the Raleigh News & Observer reports.
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
Schering-Plough Corporation has announced that it has extended to stage two an ongoing Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. In this study, vicriviroc is being evaluated in a novel nucleoside-sparing regimen that is designed to provide additional options for treatment-naive patients in a once daily regimen, while preserving other drug classes for subsequent lines of treatment.
› Verified 4 days ago
Dr. Darren Dale Bray, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8600 Nicollet Ave S, Bloomington, MN 55420 Phone: 952-541-2800 | |
Linda Eelkema, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7920 Old Cedar Ave S, Bloomington, MN 55425 Phone: 952-851-1000 Fax: 952-851-1092 | |
Aner Vlodaver, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 600 W 98th St, Bloomington, MN 55420 Phone: 952-885-6150 | |
Sandhya Joshi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7920 Old Cedar Ave S, Bloomington, MN 55425 Phone: 952-428-1800 | |
Yasmin Jeanne Khan, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5320 Hyland Greens Dr, Bloomington, MN 55437 Phone: 952-993-2400 | |
Dr. Aaron Kyle Graumann, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8600 Nicollet Ave S, Bloomington, MN 55420 Phone: 605-261-5044 | |
Paul Albert Berry, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8600 Nicollet Ave S, Mail Stop 31500a, Bloomington, MN 55420 Phone: 952-887-6600 Fax: 952-886-7015 |